Reliance Pharma Fund Unrated

Value Research
Change from previous, NAV as on Oct 09, 2015
Category: Equity: Pharma
Assets: R 1,506 crore (As on Sep 30, 2015)
Expense: 2.46% (As on Mar 31, 2015)
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005
comments powered by Disqus